High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice

Nutrition and Cancer

Volumn 59, Issue 2, 2007, Pages 207-216

  Kimura, Yoshiyuki ^a,b   Sumiyoshi, Maho ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; FAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SUCROSE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CHOLESTEROL DIET; CONTROLLED STUDY; DIETARY INTAKE; LIPID DIET; MALE; METASTASIS; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SUGAR INTAKE; TUMOR GROWTH;

MUS;

EID: 36849036395     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701499537     Document Type: Article

References (44)

1. Calle EE, Rodriguez C, Walker-Thurmond K, and Thun MJ: Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348, 1625-1638, 2003.
2. Wbelan J and McEntee MF: Dietary (n-6) PUFA and intestinal tumorigenesis. J Nutr 134(Suppl 12), 3421S-3426S, 2004.
3. Thompson HJ, Zhu Z, and Jiang W: Weight control and breast cancer prevention: are the effects of educed energy intake equivalent to those of increased energy expenditure? J Nutr 134(Suppl 12), 3407S-3411S, 2004.
4. Stephenom GD and Rose DP: Breast cancer and obesity: an update. Nutr Cancer 45, 1-6, 2003.
5. Paolini M, Sapone A, Canistro D, Antonelli MA, and Chieco P: Diet and risk of cancer. Lancet 361, 257-258, 2003.
6. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, et al.: Dietary fiber in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361, 1496-1501, 2003.
7. Donaldson MS: Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 3, 1-21, 2004.
8. Rose DP, Connolly JM, and Meschter CL: Effects of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 83, 1491-1495, 1991.
9. Rao CV, Hirose Y, Indranie C, and Reddy BS: Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61, 1927-1933, 2001.
10. Katz BB and Boylan ES: Effects of reciprocal changes of diets differing in fat content on pulmonary metastasis from the 1372 rat mammary tumor. Cancer Res 49, 2477-2484, 1989.
11. Matsuzaki J, Yamaji R, Kiyomiya J, Kurebe M, Inui H, et al.: Implanted tumor growth is suppressed and survival is prolonged in sixty percent of food-restricted mice. J Nutr 130, 111-115, 2000.
12. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, and Liu K: Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomakers Prev 11, 385-391, 2002.
13. Folkman J: Angiogenesis. Annu Rev Med 57, 1-18, 2006.
14. Folkman J: Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action. Exp Cell Res 312, 594-607, 2006.
15. Folkman J: Is angiogenesis an organizing principle in biology and medicine? J Pediatr Surg 42, 1-11, 2007.
16. Mousa SA: Elevation of plasma von Willebrand factor and tumor necrosis factor-α in obese subjects and their reduction by the low molecular weight heparin tinzaparin. Int Angiol 24, 278-281, 2005.
17. Lofgren P, van Harmelen V, Reynisdottir S, Naslund E, Ryden M, et al.: Secretion of tumor necrosis factor-α shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes 49, 688-692, 2000.
18. Aldhahi W and Hamady O: Adipokines, inflammation, and the endothelium in daiabetes. Curr Diab Rep 3, 293-298, 2003.
19. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, et al.: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79-83, 1999.
20. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al.: The fatderived hormone adiponectin reverses insulin resistant associated with both lipoatrophy and obesity. Nat Med 7, 941-946, 2001.
21. Sartipy P and Loskutoff DJ: Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100, 7265-7270 2003.
22. Takahashi K, Mizuarai S, Araki H, Mashiko S, Ishihara A, et al.: Adiposity elevates plasma MCP-1 levels leading to the increased CD 11β-positive monocytes in mice. J Biol Chem 278, 46654-46669, 2003.
23. Lehrke M and Lazar MA: Inflammed about obesity. Nat Med 10, 126-127, 2004.
24. Simeoni E, Hoffman MM, Winkelmann BR, Ruiz J, Fleury S, et al.: Association between the AG-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 47, 1574-1580, 2004.
25. Christiansen T, Richelsen B, and Bruun JM: Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes Relat Metab Disord 29, 146-150, 2005.
26. Bruun JM, Lihn AS, Pedersen SB, and Richelsen B: Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90, 2282-2289, 2005.
27. Dimova EY and Kietzamann T: The MAPK pathway and HIF-1 are involved in the induction of the human PAI-1 gene expression by insulin in the human hepatoma cell line HepG2. Ann N Y Acad Sci 1090, 355-367, 2006.
28. Chen B, Lam KS, Wang Y, Wu D, Lam MC, et al.: Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun 341, 549-556, 2006.
29. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Carfena G, Papapetropoulos A, et al.: Biological action of leptin as an angiogenic factor. Science 281, 1683-1686, 1988.
30. Suganami E, Takagi H, Ohashi H, Suzuma K, Suzuma I, et al.: Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes 53, 2443-2448, 2004.
31. Hausman GJ and Richarfson RL: Adipose tissue angiogenesis. J Anim Sci 82, 925-934, 2004.
32. Martin G, Schlunk G, Hansen LL, and Agostini HT: Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 242, 321-326, 2004.
33. Kim MY, Byeon CW, Hong KH, Jan KH, and Jeong S: Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide. FEBS Lett 579, 1597-1601, 2005.
34. Bråkenjielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, et al.: Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 101, 2476-2481, 2004.
35. Hanahan D and Folkman J: Patterns and emerging mechanism of the angiogenesis switch during tumorigenesis. Cell 86, 353-364, 1996.
36. Powis G and Kirkpatrick L: Hypoxia inducible factor-1a as a cancer drug target. Mol Cancer Ther 3, 647-654, 2004.
37. Wincewicz A, Sulkowska M, Koda M, and Sulkowski S: Clinicopathological significance andlinkage of the distribution of HIF-1α and Glut-1 in human primary colorectal cancer. Pathol Oncol Res 13, 15-20, 2007.
38. Fletcher MJ: A colorimetric method for estimating serum triglycerides. Clin Chim Acta 22, 393-397, 1968.
39. Zak B, Dickman RC, White EG, Burnett H, and Cherney PJ: Rapid estimation of free and total cholesterol. Am J Clin Pathol 24, 1307-1315, 1954.
40. Rose DP, Komninou D, and Stephenson GD: Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5, 153-165, 2004.
41. Ribeiro R, Vasconcelos A, Costa S, Pinto D, Morais A, et al.: Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 59, 268-274, 2004.
42. Markowska A, Malendowicz K, and Drews K: The role of leptin in breast cancer. Eur J Gynaecol Oncol 25, 192-194, 2004.
43. Semenza GL: Involvement of hypoxia-inducible factor 1 in human cancer. Intern Med 41, 79-83, 2002.
44. Welsh S, Williams R, Kirkpatrick L, Paine-Murrieta G, and Powis G: Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α. Mol Cancer Ther 3, 233-244, 2004.